Discriminating promiscuous from target‐specific autoantibodies in COVID‐19
Abstract: Diverse autoantibodies were suggested to contribute to severe outcomes of COVID‐19, but their functional implications are largely unclear. ACE2, the SARS‐CoV‐2 receptor and a key regulator of blood pressure, was described to be one of many targets of autoantibodies in COVID‐19. ACE2 in its soluble form (sACE2) is highly elevated in the blood of critically ill patients, raising the question of whether sACE2:spike complexes induce ACE2 reactivity. Screening 247 COVID‐19 patients, we observed elevated sACE2 and anti‐ACE2 IgG that were poorly correlated. Interestingly, levels of IgGs recognizing ACE2, IFNα2, and CD26 strongly correlated in severe COVID‐19, with 15% of sera showing polyreactivity versus 4.1% exhibiting target‐directed autoimmunity. Promiscuous autoantibodies failed to impair the activity of ACE2 and IFNα2, while only specific anti‐IFNα2 IgG compromised cytokine function. Our study suggests that the detection of autoantibodies in COVID‐19 is often attributed to a promiscuous reactivity, potentially misinterpreted as target‐specific autoimmunity with functional impact.
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Discriminating promiscuous from target‐specific autoantibodies in COVID‐19 ; day:03 ; month:04 ; year:2023 ; extent:9
European journal of immunology ; (03.04.2023) (gesamt 9)
- Creator
-
Lebedin, Mikhail
García, Clara Vázquez
Spatt, Lisa
Ratswohl, Christoph
Thibeault, Charlotte
Ostendorf, Lennard
Alexander, Tobias
Paul, Friedemann
Sander, Leif Erik
Kurth, Florian
de la Rosa, Kathrin
- DOI
-
10.1002/eji.202250210
- URN
-
urn:nbn:de:101:1-2023040415060716005921
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lebedin, Mikhail
- García, Clara Vázquez
- Spatt, Lisa
- Ratswohl, Christoph
- Thibeault, Charlotte
- Ostendorf, Lennard
- Alexander, Tobias
- Paul, Friedemann
- Sander, Leif Erik
- Kurth, Florian
- de la Rosa, Kathrin
Other Objects (12)
The German healthcare system
Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases
Can we prevent or treat multiple sclerosis by individualised vitamin D supply?
An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Correction to: An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy
The implication of natural killer cells and neutrophils in autoimmune disorders of the central nervous system
Langfristige Therapie mit Interferon-β 1a subkutan: Klinischer Verlauf und Genexpressionsveränderungen im Blut von Patienten mit schubförmig verlaufender Multipler Sklerose
The effect of omega-3 fatty acids on central nervous system remyelination in fat-1 mice
Exercise in multiple sclerosis -- an integral component of disease management
Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial
The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigue
The German healthcare system
Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases
Can we prevent or treat multiple sclerosis by individualised vitamin D supply?
An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Correction to: An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy
The implication of natural killer cells and neutrophils in autoimmune disorders of the central nervous system
Langfristige Therapie mit Interferon-β 1a subkutan: Klinischer Verlauf und Genexpressionsveränderungen im Blut von Patienten mit schubförmig verlaufender Multipler Sklerose
The effect of omega-3 fatty acids on central nervous system remyelination in fat-1 mice
Exercise in multiple sclerosis -- an integral component of disease management
Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial
The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigue
The German healthcare system
Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases
Can we prevent or treat multiple sclerosis by individualised vitamin D supply?
An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Correction to: An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy
The implication of natural killer cells and neutrophils in autoimmune disorders of the central nervous system
Langfristige Therapie mit Interferon-β 1a subkutan: Klinischer Verlauf und Genexpressionsveränderungen im Blut von Patienten mit schubförmig verlaufender Multipler Sklerose
The effect of omega-3 fatty acids on central nervous system remyelination in fat-1 mice
Exercise in multiple sclerosis -- an integral component of disease management
Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial